Gavi facts and figures

in page functions
[French]

Statistics measuring Gavi, the Vaccine Alliance's impact on global immunisation

Every year, academics, journalists, teachers and students ask for statistics detailing Gavi's results since the Vaccine Alliance was established in 2000. Sourcing the Gavi Secretariat and members of the Vaccine Alliance, including WHO, UNICEF and civil society organisations, these key facts and figures list Gavi's achievements to date as well as demonstrating the Vaccine Alliance's catalytic role within global immunisation.

US$ 80-100 billion

Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.

Source: Stack M et al. Estimated economic benefits during Decade of Vaccines, Health Affairs 2011

62 million

In 2016 alone, 62 million children were immunised with Gavi-supported vaccines. This equates to more than 185 million points of contact between these children and the primary health system and provides a robust platform for other health interventions.

Source: WHO/UNICEF 2017

>200

Gavi supported over 200 vaccine introductions and campaigns in the 2011–2015 period – four times as many as in the previous five years.

Source: Gavi

>60

The Vaccine Alliance has helped to strengthen health systems and immunisation services in more than 60 countries.

Source: Gavi

>1 million

Since the first human papillomavirus (HPV) vaccine demonstration programme in Kenya in 2013, over 1 million girls have been immunised with Gavi support. By the end of 2016, Gavi was supporting national HPV vaccine programmes in Honduras, Rwanda and Uganda.

Source: Gavi

40 million

In September 2014, Nepal became the first country to introduce inactivated polio vaccine (IPV) with Gavi support. By the end of 2016, 54 countries had introduced the vaccine with our support, collectively immunising more than 40 million children.

Source: Gavi

41 million

Since 2007, countries have immunised 41 million children with a second dose of measles or measles-rubella vaccine with Gavi support. Gavi-funded campaigns with these two vaccines have helped vaccinate another 328 million children in countries at high risk of outbreaks.

Source: WHO/UNICEF and Gavi, 2017

>100 million

Since 2011, Gavi-supported yellow fever campaigns have protected over 98 million people in 14 countries. We have also helped 17 countries introduce yellow fever vaccine through routine immunisation, immunising more than 100 million children.

Source: Gavi

>2 million

Since its creation in 2013, the global oral cholera vaccine stockpile has been used to vaccinate more than 2 million people. In 2016, eight countries – the Democratic Republic of the Congo, Haiti, Mozambique, Malawi, Niger, Somalia, South Sudan and Zambia – accessed the stockpile.

Source: Gavi

US$ 1 = US$ 18

A study in Health Affairs covering 73 Gavi-supported countries over the 2011–2020 period shows that, for every US$ 1 spent on immunisation, US$ 18 are saved in healthcare costs, lost wages and lost productivity due to illness. If we take into account the broader benefits of people living longer, healthier lives, the return on investment rises to US$ 48 per US$ 1 spent.

Source: Ozawa S, Clark S, Portnoy A et al. Return on investment from childhood immunizations in low- and middle-income countries, 2011-20, Health Affairs 2016

Source:

Source:

Source:

Source:

Source:

Source:

Source:

Source:

Source:

Source:

Source:

Source:

Source:

Source:

Source:

close icon

modal window here